Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Iridex Cp (IRIX)

Iridex Cp (IRIX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,474
  • Shares Outstanding, K 13,789
  • Annual Sales, $ 43,450 K
  • Annual Income, $ -8,810 K
  • 60-Month Beta 1.14
  • Price/Sales 0.69
  • Price/Cash Flow N/A
  • Price/Book 1.41

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.22
  • Number of Estimates 2
  • High Estimate -0.21
  • Low Estimate -0.24
  • Prior Year -0.18
  • Growth Rate Est. (year over year) -22.22%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.95 +17.18%
on 06/26/20
2.60 -12.12%
on 06/08/20
-0.08 (-3.59%)
since 06/05/20
3-Month
1.46 +56.51%
on 05/15/20
2.96 -22.80%
on 06/03/20
+0.61 (+36.01%)
since 04/07/20
52-Week
1.22 +87.30%
on 04/03/20
4.45 -48.65%
on 07/08/19
-1.91 (-45.60%)
since 07/05/19

Most Recent Stories

More News
Global Ophthalmic Lasers Market 2020 with Top Countries Data: Global Industry Trends, Market Size, Growth, Segmentation, Future Demands, Latest Innovation, Sales Revenue by Regional Forecast to 2026

A recent report provides crucial insights along with application based and forecast information in the Global Ophthalmic Lasers Market. The report provides a comprehensive analysis of key factors that...

ABT : 92.46 (-0.55%)
ELXMF : 0.4200 (unch)
IRIX : 2.29 (+3.39%)
NVS : 87.80 (-0.75%)
QUTEF : 12.8966 (+18.32%)
TOPCF : 7.5600 (-6.09%)
VRX.TO : 30.80 (-3.33%)
Global Ophthalmic Lasers Market Size,Growth 2020 Global Growth, Opportunities, Trends, Regional Overview, Leading Company Analysis, And Key Country Forecast to 2026

A recent report provides crucial insights along with application based and forecast information in the Global Ophthalmic Lasers Market. The report provides a comprehensive analysis of key factors that...

ABT : 92.46 (-0.55%)
ELXMF : 0.4200 (unch)
IRIX : 2.29 (+3.39%)
NVS : 87.80 (-0.75%)
QUTEF : 12.8966 (+18.32%)
TOPCF : 7.5600 (-6.09%)
VRX.TO : 30.80 (-3.33%)
The Global Plastic Surgery Market is expected to grow from USD 34,957.74 Million in 2018 to USD 51,849.84 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 5.79%

Reportlinker.com announces the release of the report "Global Plastic Surgery Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025" - https://www.reportlinker.com/p05871323/?utm_source=GNW...

IRIX : 2.29 (+3.39%)
Iridex (IRIX) Reports Q1 Loss, Misses Revenue Estimates

Iridex (IRIX) delivered earnings and revenue surprises of 29.41% and -5.14%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

IRIX : 2.29 (+3.39%)
Iridex: 1Q Earnings Snapshot

MOUNTAIN VIEW, Calif. (AP) _ Iridex Corp. (IRIX) on Monday reported a loss of $1.7 million in its first quarter.

IRIX : 2.29 (+3.39%)
IRIDEX Announces First Quarter 2020 Financial Results

IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the first quarter ended March 28, 2020.

IRIX : 2.29 (+3.39%)
Global Ophthalmic Lasers Market 2020 Research by Top Manufacturers, Segmentation, Industry Growth, Size, Regional Analysis and Forecast by 2026

An empirical report titled released by shows detailed market insights using tables, pie charts, graphs & figures spread through pages. The report analyzes the most recent occasions in the market such...

IRIX : 2.29 (+3.39%)
NVS : 87.80 (-0.75%)
QUTEF : 12.8966 (+18.32%)
VRX.TO : 30.80 (-3.33%)
Global Ophthalmic Laser Devices Market 2020 Research by Top Manufacturers, Segmentation, Industry Growth, Size, Regional Analysis and Forecast by 2026

aims to cover market size, share, trends, and growth analysis on the basis of different parameters. The latest market research study analyzes the current status of the market along with the historical...

CZMWF : 93.0396 (-2.06%)
ELXMF : 0.4200 (unch)
IRIX : 2.29 (+3.39%)
NVS : 87.80 (-0.75%)
QUTEF : 12.8966 (+18.32%)
VRX.TO : 30.80 (-3.33%)
IRIDEX to Report First Quarter 2020 Financial Results on May 11, 2020

IRIDEX Corporation (Nasdaq: IRIX) today announced the Company will release financial results for the first quarter of 2020 after the close of trading on Monday, May 11, 2020. The Company's management team...

IRIX : 2.29 (+3.39%)
IRIDEX Announces the Appointment of Doris Engibous to its Board of Directors

IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the appointment of Doris Engibous...

IRIX : 2.29 (+3.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Trade IRIX with:

Business Summary

IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors....

See More

Key Turning Points

2nd Resistance Point 2.39
1st Resistance Point 2.34
Last Price 2.29
1st Support Level 2.20
2nd Support Level 2.11

See More

52-Week High 4.45
Fibonacci 61.8% 3.22
Fibonacci 50% 2.84
Fibonacci 38.2% 2.45
Last Price 2.29
52-Week Low 1.22

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar